TRPV1 antagonist (AntalGenics)

N/A

Report date: 2025/01/26 16:48:42
NME

Base Information

Drug NameTRPV1 antagonist (AntalGenics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsPruritusDermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAntalGenics SL
China Registration ClassN/A

Develop Information

Active CompaniesAntalGenics SL
Inactive CompaniesN/A
Active IndicationsPruritusDermatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A